SCHEMBL1195012

SCHEMBL1195012

CC(Br)CCCCCCCCCC(=O)O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.55
LMNA P02545 2/20 0.55
NFKB1 P19838 1/20 0.55
PMP22 Q01453 1/20 0.55
FFAR4 Q5NUL3 2/20 0.53
FFAR1 O14842 2/20 0.53
ALDH1A1 P00352 3/20 0.52
GPR84 Q9NQS5 6/20 0.50
PPARG P37231 6/20 0.50
PPARD Q03181 6/20 0.50
PPARA Q07869 6/20 0.50
HDAC11 Q96DB2 5/20 0.50
TLR2 O60603 2/20 0.50
TDP1 Q9NUW8 2/20 0.50
FABP4 P15090 2/20 0.50
PTPN1 P18031 2/20 0.50
GSTK1 Q9Y2Q3 1/20 0.50
SLC22A6 Q4U2R8 1/20 0.50
SLC22A8 Q8TCC7 1/20 0.50
MEN1 O00255 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2704335 1.00 TSHR (0.55) TSHRLMNANFKB1PMP22FFAR4
SCHEMBL8864332 1.00 TSHR (0.55) TSHRLMNANFKB1PMP22FFAR4
SCHEMBL28582984 1.00 TSHR (0.55) TSHRLMNANFKB1PMP22FFAR4
SCHEMBL23829849 1.00 TSHR (0.55) TSHRLMNANFKB1PMP22FFAR4
SCHEMBL1980374 1.00 TSHR (0.55) TSHRLMNANFKB1PMP22FFAR4
SCHEMBL23854568 1.00 TSHR (0.55) TSHRLMNANFKB1PMP22FFAR4
SCHEMBL5848589 1.00 TSHR (0.55) TSHRLMNANFKB1PMP22FFAR4
SCHEMBL5974021 1.00 TSHR (0.55) TSHRLMNANFKB1PMP22FFAR4
SCHEMBL11595992 1.00 TSHR (0.55) TSHRLMNANFKB1PMP22FFAR4
SCHEMBL4655081 0.98 LMNA (0.52) TSHRLMNANFKB1PMP22FFAR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210289794-A1 COMPOSITIONS AND RELATED METHODS FOR AGRICULTURE FLAGSHIP PIONEERING INNOVATIONS V, INC. 2021-09-23 US disclosed
CN-108329746-A Compound for reducing background colour in color change composition 西甘产业股份有限公司 2018-07-27 CN disclosed
CN-105283317-B Compounds for reducing background color in color change compositions 西甘产业股份有限公司 2018-02-06 CN disclosed
CN-105283317-A Compounds for reducing background color in color change compositions SEGAN IND INC 2016-01-27 CN disclosed
US-7887835-B2 for vascular lesion imaging and for diagnosing arteriosclerosis, ischemia with X-ray angiography and positron emission tomography; fluorinated steroid ester, glyceride compounds, phosphatidylcholine, and phosphatidylserine as membrane components of liposome FUJIFILM CORPORATION (JP) 2011-02-15 US disclosed
US-20080138285-A1 Compound comprising a fluorine-substituted alkyl group and a liposome contrast medium comprising the compound FUJIFILM CORPORATION (JP) 2008-06-12 US disclosed
EP-1916255-A2 Compound comprising a fluorine-substituted alkyl group and a liposome contrast medium comprising the compound FUJIFILM Corporation (JP) 2008-04-30 EP disclosed
US-5879438-A CONTAINING SPECIFIC ELECTRON ACCEPTING LIGHTFASTNESS PROVIDING AGENT THE PILOT INK CO., LTD. (JP) 1999-03-09 US disclosed
US-5873932-A BLENDING AN ELECTRON DONATING COMPOUND, AN ELECTRON ACCEPTING COMPOUND, A METACHROMATIC TEMPERATURE ADJUSTER, AN ELECTRON ACCEPTING, LIGHT-FASTNESS PROVIDING AGENT THE PILOT INK CO., LTD. (JP) 1999-02-23 US disclosed
US-5128462-A Hydrophobically modified carboxyalkyl hydroxyalkyl ethers of polygalactomannans RHONE-POULENC INC. (US) 1992-07-07 US disclosed
US-4845271-A Process for the preparation of omega-unsaturated carboxylic acids AKZO AMERICA INC. (US) 1989-07-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080138285-A1 Compound comprising a fluorine-substituted alkyl group and a liposome contrast medium comprising the compound PHOSPHO1, SGMS1, SGMS2 TSHR 1934/4885LMNA 456/4885NFKB1 1053/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.